Company Filing History:
1 out of 208 
1 out of 23 
1 out of 1 Years Active: 2010-2018
Title: Tiejun Li: Innovator in Medical Technology
Introduction
Tiejun Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly in the development of innovative treatments for various diseases. With a total of 3 patents, his work has the potential to impact the medical community significantly.
Latest Patents
One of Tiejun Li's latest patents is the "Application of cyclic dinucleotide (cGAMP) in anti-tumor field." This invention focuses on the use of cGAMP in tumor treatment, demonstrating its ability to inhibit the growth of various tumor cells. Research indicates that cGAMP can be utilized in the preparation of anti-tumor drugs, which exhibit low toxicity and favorable effects. In studies conducted using a subcutaneous tumor model in nude mice, cGAMP showed remarkable inhibition effects on several human cancer cell lines, including gastric carcinoma, lung adenocarcinoma, colorectal carcinoma, hepatocellular carcinoma, prostatic carcinoma, and pancreatic carcinoma. Another notable patent is the "Method for treating myocardial ischemia," which involves the use of the polypeptide micromolecule MLIF for preventing and treating myocardial ischemia. The amino acid sequence of this polypeptide is Met-Gln-Cys-Asn-Ser (SEQ ID NO:1).
Career Highlights
Tiejun Li has worked with esteemed institutions such as Fudan University and Shanghai Micro Electronics Equipment Co., Ltd. His experience in these organizations has contributed to his expertise in medical technology and innovation.
Collaborations
Throughout his career, Tiejun Li has collaborated with notable colleagues, including Yaocheng Rui and Yuefan Zhang. These partnerships have fostered a collaborative environment that enhances the development of innovative medical solutions.
Conclusion
Tiejun Li's contributions to medical technology through his patents and collaborations highlight his role as an influential inventor. His work in developing treatments for tumors and myocardial ischemia showcases the potential for innovation in the medical field.